about
Future development of global regulations of Chinese herbal productsDetermination of icariin in rat plasma by reverse-phase high-performance liquid chromatography after oral administration of a lipid-based suspension of Epimedium koreanum extract.Effect of lipid-based suspension of Epimedium koreanum Nakai extract on sexual behavior in rats.Medicinal plants of the Russian Pharmacopoeia; their history and applications.Bergenia crassifolia (L.) Fritsch--pharmacology and phytochemistry.ID-CUBE direct analysis in real time high-resolution mass spectrometry and its capabilities in the identification of phenolic components from the green leaves of Bergenia crassifolia L.Pharmacological evaluation of Potentilla alba L. in mice: adaptogenic and central nervous system effects.Antiallergic effects of pigments isolated from green sea urchin (Strongylocentrotus droebachiensis) shells.Chemical and antioxidant evaluation of Indian gooseberry (Emblica officinalis Gaertn., syn. Phyllanthus emblica L.) supplements.Chemical composition and in vitro antioxidant evaluation of commercial water-soluble willow herb (Epilobium angustifolium L.) extracts.Determination and pharmacokinetic study of taxifolin in rabbit plasma by high-performance liquid chromatography.Comparison of high performance TLC and HPLC for separation and quantification of chlorogenic acid in green coffee bean extracts.Separation and free radical-scavenging activity of major curcuminoids of Curcuma longa using HPTLC-DPPH method.Effect of Bergenia crassifolia L. extracts on weight gain and feeding behavior of rats with high-caloric diet-induced obesity.Comparative stability of dimeric and monomeric pigments extracted from sea urchin Strongylocentrotus droebachiensis.Effect of Leonurus cardiaca oil extract in patients with arterial hypertension accompanied by anxiety and sleep disorders.Rapid profiling of phenolic compounds of green and fermented Bergenia crassifolia L. leaves by UPLC-DAD-QqQ-MS and HPLC-DAD-ESI-QTOF-MS.Characterization of volatile and semi-volatile compounds in green and fermented leaves of Bergenia crassifolia L. by gas chromatography-mass spectrometry and ID-CUBE direct analysis in real time-high resolution mass spectrometry.Separation and evaluation of free radical-scavenging activity of phenol components of green, brown, and black leaves of Bergenia crassifolia by using HPTLC-DPPH* method.Oplopanax elatus (Nakai) Nakai: chemistry, traditional use and pharmacologyBlood pressure-lowering properties of chokeberry (Aronia mitchurinii, var. Viking)Separation and quantification of terpenoids of Boswellia serrata Roxb. extract by planar chromatography techniques (TLC and AMD)Comparison between HPLC and HPTLC densitometry for the determination of icariin from Epimedium koreanum extractsSeparation and evaluation of free radical-scavenging activity of phenol components of Emblica officinalis extract by using an HPTLC-DPPH* methodAntibacterial activity of Chamomilla recutita oil extract against Helicobacter pyloriThe offline combination of thin-layer chromatography and high-performance liquid chromatography with diode array detection and micrOTOF-Q mass spectrometry for the separation and identification of spinochromes from sea urchin (Strongylocentrotus dro
P50
Q27026100-AD22A129-4A79-4186-8147-8B6070DE6366Q33318488-07CE1DF9-49E4-47DF-AD41-FC79CAB7BA1CQ34692117-E9543DE3-EAF0-43B4-A9C5-8B6B36C42AEDQ35151412-22C9DB08-7343-4C5C-B51A-32E93179BBD9Q38274252-90A2DF60-D41E-498D-A3BF-396C48016FBAQ39621604-E361F728-86CE-448A-91BF-82A8C5EB2C35Q42594812-64252D8A-595B-4C40-B202-42D1EF4E44D6Q45280779-5A073D28-6CA4-42C0-BD16-368F328C4700Q46144992-56D93026-FF8C-4259-8840-72C2ABB74800Q46172845-B0F5689F-424B-44D1-A791-09274D3C4E1AQ46182298-EAE5C6EC-784F-4760-A06B-DFBD583D52B0Q46816652-8D6A0571-BC58-4976-8DD9-C5E470888163Q46955957-BA10790D-4464-471F-AC00-260BD5BED5D0Q47278055-55501834-B49B-40DF-AC47-120260EE8411Q48143941-EA9947AF-8C40-4CAB-A6D5-0D347DE93CD5Q48340953-B2A22B50-FEA9-4B9F-94E2-1463E92E19CEQ50455255-463A322C-6F7A-4787-A0DC-F30339C773B1Q50455269-F644A40A-DC1B-4D69-A593-150B0A3BC1D1Q50667383-413F6E30-FEE5-4B2F-ACD0-1032FC1C4261Q57222273-40EF943D-3608-4732-8544-C11C6DF46192Q59512127-D0548F1E-AEB2-486A-B685-5BA0462A2ECFQ79307921-EC6E7418-9F75-41DE-8D7E-E93FDC0C6526Q80221746-74EB281C-7DEE-481D-8347-00849E529E6DQ80594952-95837C31-4CB3-4408-81AD-8BDCB265B7A3Q80855171-9F515866-E142-48DA-8943-0A4717BA597AQ82478010-0B56C884-6065-43ED-BF4F-DCEC947056C6
P50
description
Russian pharmacologist
@en
wetenschapper
@nl
name
Valery Makarov
@ast
Valery Makarov
@en
Valery Makarov
@es
Valery Makarov
@nl
type
label
Valery Makarov
@ast
Valery Makarov
@en
Valery Makarov
@es
Valery Makarov
@nl
altLabel
Valery G. Makarov
@en
prefLabel
Valery Makarov
@ast
Valery Makarov
@en
Valery Makarov
@es
Valery Makarov
@nl
P106
P1153
7401690256
P31
P496
0000-0002-2447-7888